Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Website issue

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Aug 20, 2021 10:50pm

153 Views

Post# 33744329

RE:RE:RE:RE:RE:RE:Website issue

Oddly, it's only the EN version missing the Investors tab. It's still up on the FR version. Maybe they're sending a message!

Wino115 wrote: Pages are still up there, just not the opening menu to choose them. For instance, here's the presentation page with today's closing share price. But probably they're revamping it for next week and later.

https://www.theratech.com/investors/news-events/presentations

Lee430 wrote: Mr. Holler's pic does leave a lot to the imagination....or I understand Vampires can't be photographed ;-O

Wino115 wrote: And our new Board member looks like a Monet painting.... or Minecraft avatar.

Lee430 wrote: Sooo is this a good omen?